Pulling SEC filings + quote and writing the call…

MICRON TECHNOLOGY INC
Next earnings Jun 24, 2026 (after close) · consensus $20.69 EPS, $35.9B rev
Last earnings -0.3% on 2026-06-24
Phenomenal AI/HBM upcycle, but at 138x earnings and 31x sales on peak-cycle memory profits the price discounts perfection.
P/E (price / FY diluted EPS) 138.1 · on FY2025 EPS $7.59
Weak on both the fundamentals and the price — little to like at the current level.
Operationally Micron is firing on all cylinders. FY2025 revenue jumped 48.9% to $37.4B and net income exploded ~998% to $8.54B as the AI cycle lifted DRAM. Management is explicit: 'AI-driven demand is accelerating and is outpacing industry supply,' with DRAM sales +62% on a low-40% range increase in average selling prices and a richer HBM mix. Consolidated gross margin swung from 22% in FY2024 to 39.8% in FY2025 (and from negative 9% in FY2023), operating margin reached 26.1%, and operating cash flow doubled to $17.5B. The balance sheet is sound — liabilities/equity of just 0.53x, $9.64B cash against $11.5B long-term debt, and $48.6B retained earnings. As a business in this moment, it is excellent.
The problem is the price, not the company. At $1,048.51 the stock trades at 138x trailing diluted EPS of $7.59 and 31.5x sales — software-like multiples applied to a deeply cyclical, capital-intensive memory maker. Crucially, that 138x P/E sits on top of PEAK-cycle earnings: a high multiple on peak profits is the opposite of what cyclicals deserve. The provided five-year history is the warning — revenue collapsed from $30.8B (FY2022) to $15.5B (FY2023) with a $5.83B net loss and negative 9% gross margin, then earnings cratered to $778M in FY2024 before this year's rebound. Memory ASPs that rose 40%+ can fall just as fast when supply catches demand, which the MD&A concedes Micron actively manages around.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 7:39 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $27.7B | $30.8B | $15.5B | $25.1B | $37.4B |
| Gross profit | $10.4B | $13.9B | -$1.42B | $5.61B | $14.9B |
| Operating income | $6.28B | $9.70B | -$5.75B | $1.30B | $9.77B |
| Net income | $5.86B | $8.69B | -$5.83B | $778M | $8.54B |
| Diluted EPS | $5.14 | $7.75 | -$5.34 | $0.70 | $7.59 |
| Net margin | 21.2% | 28.2% | -37.5% | 3.1% | 22.8% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q3 FY26 (May-28): AI-led DRAM/HBM strength sustains high margins and cash flow
Q3 FY26 results released; AI/HBM demand continuing to drive record DRAM revenue
Officer/director change (Item 5.02) — leadership transition, no financial impact disclosed
Other event disclosure (Item 8.01) with exhibits; no earnings or guidance change
Other event disclosure (Item 8.01) with exhibits; informational filing
Q2 FY26: continued ASP gains and HBM mix lift gross margin year-over-year
Q2 FY26 earnings released; strong DRAM/HBM pricing extends profitability surge
Annual meeting: vote results (5.07) + charter/bylaw change (5.03); routine governance
Q1 FY26: momentum from FY25 boom continues; DRAM pricing and volumes strong
Sources: SEC EDGAR (CIK 0000723125, latest 10-Q filed 2026-06-25) · EODHD · Proprietary analysis · as of 6/25/2026, 11:39:20 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 86 sales
| 2026-06-30 | Dugle Lynn A Director | Sell | 1.30K @ $1,150.43 | $1.50M |
| 2026-06-30 | Dugle Lynn A Director | Gift | 700.00 | |
| 2026-06-30 | Liu Teyin M Director | Award | 27.00 | |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 496.00 @ $1,170.60 | $581K |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 857.00 @ $1,172.57 | $1.00M |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 243.00 @ $1,173.83 | $285K |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 489.00 @ $1,175.17 | $575K |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 1.33K @ $1,177.28 | $1.56M |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 1.09K @ $1,178.06 | $1.28M |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 680.00 @ $1,179.51 | $802K |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 1.24K @ $1,180.17 | $1.46M |
| 2026-06-26 | MEHROTRA SANJAY President and CEO | Sell | 209.00 @ $1,181.20 | $247K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
6 buys · 6 sells · 5 members · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Crowd attention, not a quality signal — weigh it against the figures above. All trending →